ESC Premium Access

Clinical course and related costs of patients with diabetes and heart failure and/or chronic kidney disease, drawn from a sample of more than 7 million people

Congress Session

About the speaker

Professor Aldo Pietro Maggioni

ANMCO Research Center, Florence (Italy)
29 presentations
3 followers

4 more presentations in this session

Clinical outcomes and death associated with cardiorenal syndromes. A comprehensive nationwide cohort study

Speaker: Professor L. Fauchier (Tours, FR)

Thumbnail

Long-term evolution of estimated glomerular filtration rate in heart failure

Speaker: Doctor C. Escabia Riera (Badalona, ES)

Thumbnail

Influence of diabetes, heart failure, and NT-proBNP on cardiovascular outcomes in patients with atrial fibrillation - Insights from a cohort study of 7,412 patients with extended follow-up

Speaker: Doctor F. Hofer (Vienna, AT)

Thumbnail

Outcomes of diabetic patients with end-stage heart failure listed for heart transplantation: a propensity-matched analysis

Speaker: Assistant Professor A. Briasoulis (Iowa City, US)

Thumbnail

Access the full session

Diabetes and kidney disease in heart failure: how should we treat the terrible triplets?

Speakers: Professor A. Maggioni, Professor L. Fauchier, Doctor C. Escabia Riera, Doctor F. Hofer, Assistant Professor A. Briasoulis
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Renal decline in patients with atrial fibrillation treated with rivaroxaban or warfarin: a population-based cohort study in the United Kingdom

27 August 2021

ESC Premium Access

Effects of Sacubitril/valsartan compared with ramipril on coronary events after myocardial infarction - Results from the PARADISE-MI Trial

27 August 2021

ESC Premium Access

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

27 August 2021

This platform is supported by

logo Novo Nordisk